We further analyzed ADAM12 expression in publicly available datasets from cohorts of patients with skin cutaneous melanoma, pancreatic ductal adenocarcinoma, prostate adenocarcinoma or colon adenocarcinoma. This evidence concerns the gene ADAM12 and cutaneous melanoma.